Literature DB >> 28495717

Myriad take two: Can genomic databases remain secret?

Christi J Guerrini1, Amy L McGuire2, Mary A Majumder2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28495717     DOI： 10.1126/science.aal3224

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

1.  Patients v. Myriad or the GDPR Access Right v. the EU Database Right.

Authors:  Jasper A Bovenberg; Mara Almeida
Journal:  Eur J Hum Genet       Date:  2018-09-27       Impact factor: 4.246

2.  [Centralized molecular tumor diagnostics by commercial providers : Consequences for patients, patient care, and research].

Authors:  P Schirmacher; A Stenzinger; T Kirchner
Journal:  Pathologe       Date:  2018-11       Impact factor: 1.011

Review 3.  Discouraging Elective Genetic Testing of Minors: A Norm under Siege in a New Era of Genomic Medicine.

Authors:  Laura Hercher
Journal:  Cold Spring Harb Perspect Med       Date:  2020-05-01       Impact factor: 6.915

4.  A Commentary on Commercial Genetic Testing and the Future of the Genetic Counseling Profession.

Authors:  Nicholas D Wolff; Jon A Wolff
Journal:  J Genet Couns       Date:  2018-03-09       Impact factor: 2.537
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.